Showing 301 - 320 results of 554 for search '(( significant decrease decrease ) OR ( significantly ((lower decrease) OR (mean decrease)) ))~', query time: 0.41s Refine Results
  1. 301

    Cumulative meta-analysis. by Alvine M. Akumbom (20460907)

    Published 2024
    “…GMT results of HPV16 and HPV18 genotypes were significantly lower in PWH; Hedges’s g -0.434 (95% CI: -0.823, -0.046) and Hedges’s g -0.57 (95% CI: -0.72, -0.43), respectively. …”
  2. 302

    Summary of immunogenicity information. by Alvine M. Akumbom (20460907)

    Published 2024
    “…GMT results of HPV16 and HPV18 genotypes were significantly lower in PWH; Hedges’s g -0.434 (95% CI: -0.823, -0.046) and Hedges’s g -0.57 (95% CI: -0.72, -0.43), respectively. …”
  3. 303

    Baseline characteristics of the study population. by Hanbin Wu (14016246)

    Published 2025
    “…Among underweight women, preconception hypoglycemia was associated with a lower risk of medical abortion, miscarriage or early stillbirth, LGA, and PID, while overweight women had a lower risk of macrosomia and LGA. …”
  4. 304

    Minimal data set. by Daan P. van den Brink (9900073)

    Published 2025
    “…</p><p>Results</p><p>Inoculated animals developed pneumosepsis, with lower mean arterial pressures (p < 0.001) and higher lactate levels (p < 0.001) compared to healthy controls. …”
  5. 305

    Image 1_Lower hippocampal volumes at baseline are associated with higher volume loss in healthy elderly.png by Vivian Schultz (17379235)

    Published 2025
    “…</p>Results<p>Hippocampal volumes decreased from baseline to follow-up [mean APC (SD): right −1.34% (0.94), left: −1.79% (1.00)]. …”
  6. 306

    Flow chart of research object screening. by Wenyao Xie (21567889)

    Published 2025
    “…</p><p>Results</p><p>Cancer patients had higher mean age (68.70 ± 11.85 vs. 48.36 ± 17.00 years), lower testosterone levels (377.35 ± 204.26 vs. 415.02 ± 183.92 ng/dL, P < 0.001), and lower ALI values (64.86 ± 118.61 vs. 72.68 ± 185.25, P = 0.053) than non-cancer controls. …”
  7. 307

    Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  8. 308

    Homogeneity test of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  9. 309

    Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  10. 310

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  11. 311

    fNIRS equipment coordinates. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  12. 312

    Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  13. 313

    Analysis of variance of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  14. 314

    Placement on the forehead. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  15. 315

    IMW intervention plan design. by Xinyu Dai (5100731)

    Published 2025
    “…A series of multiple comparisons demonstrated that the CR10 in the IMW group exhibited a significantly lower value than that observed in the placebo and control groups (<i>p</i> < 0.001). …”
  16. 316
  17. 317

    Comparison of Mean Absolute Error (MAE) in Millimeters as a Function of Kernel Size. by Liu Liu (512237)

    Published 2025
    “…<p>Fig 8 presents the mean absolute error (MAE) in millimeters as a function of kernel size (in pixels) for two model configurations. …”
  18. 318

    Supplementary Material for: Efficacy and safety of transdermal medical cannabis (THC:CBD: CBN formula) to treat painful diabetic peripheral neuropathy of the lower extremities by Seevathee K. (20196534)

    Published 2024
    “…Mean total NPSI-T scores decreased markedly from 25.60 to 5.57 in the treatment cohort, contrasting with minimal reduction from 25.24 to 22.85 in the placebo group. …”
  19. 319

    Study sample. by Nipaporn Butsing (19470003)

    Published 2025
    “…One increased National Institute of Health Stroke Scale (NIHSS) score decreased adjusted BI scores by 3.6.</p><p>Conclusion</p><p>The time after discharge, gender, stroke subtype, and stroke severity are significant factors affecting functional outcomes after a stroke. …”
  20. 320

    Data Sheet 1_Valve-in-valve transcatheter aortic valve replacement (TAVR) leads to lower device success compared to TAVR in native stenosis.pdf by Michael Paukovitsch (16428786)

    Published 2025
    “…The overall rate of device success amounted to 66% in ViV-TAVR, compared to 96.1% in TAVR (p < 0.01) and ViV-TAVR was independently associated with reduced device success (OR: 0.07, 95%CI: 0.045–0.12, p < 0.01) in multivariate regression. While ViV-TAVR decreased peak and mean gradients significantly, in 31% of patients elevated mean gradients (≥20 mmHg) were observed at discharge. …”